Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amgen Inc. stock logo
AMGN
Amgen
$417.31
+0.5%
$370.57
$269.77
$421.79
$225.61B0.412.72 million shs657,478 shs
The Chemours Company stock logo
CC
Chemours
$15.52
-2.1%
$18.54
$10.44
$28.67
$2.34B1.433.09 million shs547,212 shs
EOG Resources, Inc. stock logo
EOG
EOG Resources
$144.15
+1.1%
$137.57
$101.59
$151.87
$75.52B0.254.31 million shs526,507 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amgen Inc. stock logo
AMGN
Amgen
0.00%+1.04%+13.36%+28.00%+40.05%
The Chemours Company stock logo
CC
Chemours
0.00%+0.39%-9.96%-31.01%+8.35%
EOG Resources, Inc. stock logo
EOG
EOG Resources
0.00%+5.90%+1.97%-0.33%+19.73%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amgen Inc. stock logo
AMGN
Amgen
$417.31
+0.5%
$370.57
$269.77
$421.79
$225.61B0.412.72 million shs657,478 shs
The Chemours Company stock logo
CC
Chemours
$15.52
-2.1%
$18.54
$10.44
$28.67
$2.34B1.433.09 million shs547,212 shs
EOG Resources, Inc. stock logo
EOG
EOG Resources
$144.15
+1.1%
$137.57
$101.59
$151.87
$75.52B0.254.31 million shs526,507 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amgen Inc. stock logo
AMGN
Amgen
0.00%+1.04%+13.36%+28.00%+40.05%
The Chemours Company stock logo
CC
Chemours
0.00%+0.39%-9.96%-31.01%+8.35%
EOG Resources, Inc. stock logo
EOG
EOG Resources
0.00%+5.90%+1.97%-0.33%+19.73%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amgen Inc. stock logo
AMGN
Amgen
2.35
Hold$372.39-10.76% Downside
The Chemours Company stock logo
CC
Chemours
2.25
Hold$20.1029.48% Upside
EOG Resources, Inc. stock logo
EOG
EOG Resources
2.48
Hold$156.008.22% Upside

Current Analyst Ratings Breakdown

Latest CC, AMGN, and EOG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/17/2026
EOG Resources, Inc. stock logo
EOG
EOG Resources
Set Price TargetEqual Weight$153.00 ➝ $147.00
8/14/2026
Amgen Inc. stock logo
AMGN
Amgen
Boost Price TargetEqual Weight$360.00 ➝ $380.00
8/13/2026
The Chemours Company stock logo
CC
Chemours
Reiterated RatingNeutral$17.00
8/13/2026
EOG Resources, Inc. stock logo
EOG
EOG Resources
Reiterated RatingOverweight$196.00 ➝ $193.00
8/13/2026
The Chemours Company stock logo
CC
Chemours
Lower Price TargetNeutral$22.00 ➝ $15.00
8/13/2026
The Chemours Company stock logo
CC
Chemours
Lower Price TargetOutperform$26.00 ➝ $18.00
8/11/2026
The Chemours Company stock logo
CC
Chemours
DowngradeStrong-BuyStrong Sell
8/10/2026
Amgen Inc. stock logo
AMGN
Amgen
Boost Price TargetNeutral$343.00 ➝ $388.00
8/10/2026
The Chemours Company stock logo
CC
Chemours
Set Price Target$18.00
8/10/2026
The Chemours Company stock logo
CC
Chemours
Reiterated RatingBuyNeutral$29.00 ➝ $18.00
8/10/2026
The Chemours Company stock logo
CC
Chemours
DowngradeBuyNeutral$18.00
(Data available from 8/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amgen Inc. stock logo
AMGN
Amgen
$38.10B5.92$33.98 per share12.28$16.08 per share25.95
The Chemours Company stock logo
CC
Chemours
$5.81B0.40$3.23 per share4.81$1.67 per share9.30
EOG Resources, Inc. stock logo
EOG
EOG Resources
$26.64B2.84$18.65 per share7.73$54.98 per share2.62
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amgen Inc. stock logo
AMGN
Amgen
$7.71B$16.0925.9417.223.8622.95%124.14%13.18%11/3/2026 (Estimated)
The Chemours Company stock logo
CC
Chemours
-$386M-$1.91N/A7.88N/A-5.00%60.64%1.48%11/5/2026 (Estimated)
EOG Resources, Inc. stock logo
EOG
EOG Resources
$4.98B$12.8511.2010.38N/A25.44%23.44%13.58%11/5/2026 (Estimated)

Latest CC, AMGN, and EOG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2026Q2 2026
Amgen Inc. stock logo
AMGN
Amgen
$5.62$6.29+$0.67$4.37$9.43 billion$10.05 billion
8/4/2026Q2 2026
The Chemours Company stock logo
CC
Chemours
$0.4887$0.42-$0.0687-$1.81$1.65 billion$1.59 billion
8/4/2026Q2 2026
EOG Resources, Inc. stock logo
EOG
EOG Resources
$4.97$5.07+$0.10$5.15$8.04 billion$8.62 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Amgen Inc. stock logo
AMGN
Amgen
$10.082.42%+8.27%62.65%14 Years
The Chemours Company stock logo
CC
Chemours
$0.352.25%-12.60%N/A N/A
EOG Resources, Inc. stock logo
EOG
EOG Resources
$4.082.83%+22.88%31.75%8 Years

Latest CC, AMGN, and EOG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/4/2026
EOG Resources, Inc. stock logo
EOG
EOG Resources
quarterly$1.022.84%10/16/202610/16/202610/30/2026
8/4/2026
The Chemours Company stock logo
CC
Chemours
quarterly$0.08752.21%8/14/20268/14/20269/15/2026
7/30/2026
Amgen Inc. stock logo
AMGN
Amgen
quarterly$2.522.6%8/21/20268/21/20269/11/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amgen Inc. stock logo
AMGN
Amgen
4.44
1.37
1.13
The Chemours Company stock logo
CC
Chemours
18.98
1.66
0.88
EOG Resources, Inc. stock logo
EOG
EOG Resources
0.25
1.85
1.68

Institutional Ownership

CompanyInstitutional Ownership
Amgen Inc. stock logo
AMGN
Amgen
76.50%
The Chemours Company stock logo
CC
Chemours
76.26%
EOG Resources, Inc. stock logo
EOG
EOG Resources
89.91%

Insider Ownership

CompanyInsider Ownership
Amgen Inc. stock logo
AMGN
Amgen
0.85%
The Chemours Company stock logo
CC
Chemours
0.85%
EOG Resources, Inc. stock logo
EOG
EOG Resources
0.14%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amgen Inc. stock logo
AMGN
Amgen
31,500540.63 million536.04 millionOptionable
The Chemours Company stock logo
CC
Chemours
5,700150.50 million149.22 millionOptionable
EOG Resources, Inc. stock logo
EOG
EOG Resources
3,400524.53 million523.80 millionOptionable

Recent News About These Companies

S&CO Inc. Buys Shares of 10,865 EOG Resources, Inc. $EOG
EOG Resources: Upgrading To Buy
EOG Resources Q2 Earnings Call Highlights

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amgen stock logo

Amgen NASDAQ:AMGN

$417.31 +2.10 (+0.50%)
As of 01:03 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Chemours stock logo

Chemours NYSE:CC

$15.52 -0.33 (-2.06%)
As of 01:03 PM Eastern
This is a fair market value price provided by Massive. Learn more.

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical, and other applications under the eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

EOG Resources stock logo

EOG Resources NYSE:EOG

$144.15 +1.54 (+1.08%)
As of 01:03 PM Eastern
This is a fair market value price provided by Massive. Learn more.

EOG Resources, Inc., together with its subsidiaries, explores for, develops, produces, and markets crude oil, natural gas liquids, and natural gas primarily in producing basins in the United States, the Republic of Trinidad and Tobago and internationally. The company was formerly known as Enron Oil & Gas Company. EOG Resources, Inc. was incorporated in 1985 and is headquartered in Houston, Texas.